Spine surgeon Daniel Park, MD, completed the first U.S. case using Kuros Biosciences’ MagnetOs minimally invasive surgery delivery system, according to an Aug. 5 news release.
MagnetOs MIS, a bone graft delivery system, was cleared by the FDA in May. Compared to a traditional funnel-based system, Magnet OS MIS completed graft placement three times faster.
“MagnetOs MIS delivered smooth, precise graft placement in a typically challenging MIS TLIF case — no preparation, no thawing, just immediate delivery and efficiency,” Dr. Park said in the release. “It pairs streamlined handling with compelling clinical data, making it a meaningful advancement for surgeons who value both efficiency and biologically robust healing.”
A full commercial release is expected for the Fall.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
